HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells.

Abstract
PU.1 is an Ets family transcription factor essential for myelomonocyte and B-cell development. We previously showed that overexpression of PU.1 in murine erythroleukemia (MEL) cells inhibits growth and erythroid differentiation and induces apoptosis of the cells. In an effort to identify target genes of PU.1 concerning these phenomena by using a messenger RNA differential display strategy, we found that some myeloid-specific and lymphoid-specific genes, such as the osteopontin gene, are transcriptionally up-regulated in MEL cells after overexpression of PU.1. We then found that expression of several myelomonocyte-specific genes, including the CAAT-enhancer-binding protein-alpha and granulocyte-macrophage colony-stimulating factor receptor genes, was induced in MEL cells after overexpression of PU.1. B-cell-specific genes were also examined, and expression of the CD19 gene was found to be induced. Expression of the myelomonocyte-specific proteins CD11b and F4/80 antigen but not the B-cell-specific proteins B220 and CD19 was also induced. After overexpression of PU.1, MEL cells became adherent and phagocytic and showed enhanced nitroblue tetrazolium reduction activity. Expression of myelomonocyte-specific and B-cell-specific genes was not induced when a mutant PU.1 with part of the activation domain deleted (a change found to inhibit erythroid differentiation of MEL cells) was expressed. These results indicate that PU.1 induces a lineage switch in MEL cells toward myelomonocytic cells and that its activation domain is essential for this effect. The results also suggest that the pathway of the lineage switch is distinct from that of inhibition of erythroid differentiation in MEL cells.
AuthorsT Yamada, M Abe, T Higashi, H Yamamoto, F Kihara-Negishi, T Sakurai, T Shirai, T Oikawa
JournalBlood (Blood) Vol. 97 Issue 8 Pg. 2300-7 (Apr 15 2001) ISSN: 0006-4971 [Print] United States
PMID11290591 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chlorides
  • Neoplasm Proteins
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • RNA, Neoplasm
  • Recombinant Fusion Proteins
  • Trans-Activators
  • Zinc Compounds
  • proto-oncogene protein Spi-1
  • zinc chloride
Topics
  • Cell Adhesion
  • Cell Differentiation
  • Cell Lineage (genetics)
  • Cell Size
  • Chlorides (pharmacology)
  • Gene Expression Profiling
  • Gene Expression Regulation, Leukemic (drug effects)
  • Leukemia, Erythroblastic, Acute (genetics, pathology)
  • Neoplasm Proteins (biosynthesis, genetics)
  • Neoplastic Stem Cells (drug effects, metabolism)
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins (biosynthesis, chemistry, genetics, physiology)
  • RNA, Messenger (biosynthesis, genetics)
  • RNA, Neoplasm (biosynthesis, genetics)
  • Recombinant Fusion Proteins (physiology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Subtraction Technique
  • Trans-Activators (biosynthesis, chemistry, genetics, physiology)
  • Transcription, Genetic
  • Zinc Compounds (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: